Patients with Behcet's disease carry a higher risk for microvascular involvement in active disease period

References

• Koc Y., Gullu I., Akpek G., Akpolat T., Kansu E., Kiraz S., et al. Vascular involvement in Behcet's disease. J Rheumatol 1992; 19: 402–10
   PubMed Web of Science ®Google Scholar
• Ehrlich G. E. Vasculitis in Behcet's disease. Int Rev Immunol 1997; 14: 81–8
   PubMedGoogle Scholar
• Kosar F., Sahin I., Gullu H., Cehreli S. Acute myocardial infarction with normal coronary arteries in a young man with the Behcet's disease. Int J Cardiol 2005; 99: 355–7
   Web of Science ®Google Scholar
• Chambers J. C., Haskard D. O., Kooner J. S. Vascular endothelial function and oxidative stress mechanisms in patients with Behcet's syndrome. J Am Coll Cardiol 2001; 37: 517–20
   PubMed Web of Science ®Google Scholar
• Ozdemir R., Barutcu I., Sezgin A. T., Acikgoz N., Ermis N., Esen A. M., et al. Vascular endothelial function and plasma homocysteinee levels in Behcet's disease. Am J Cardiol 2004; 94: 522–5
   Google Scholar
• Gullu I. H., Benekli M., Muderrisoglu H., Oto A., Kansu E., Kabakci G., et al. Silent myocardial ischemia in Behcet's disease. J Rheumatol 1996; 23: 323–7
   Google Scholar
• Turkolmez S., Gokcora N., Alkan M., Gorer M. A. Evaluation of myocardial perfusion in patients with Behcet's disease. Ann Nucl Med 2005; 19: 201–6
   PubMed Web of Science ®Google Scholar
• Youn H. J., Foster E. Demonstration of coronary artery flow using transthoracic Doppler echocardiography. J Am Soc Echocardiogr 2004; 17: 178–85
   Google Scholar
• Dimitrow P. P. Transthoracic Doppler echocardiography—noninvasive diagnostic window for coronary flow reserve assessment. Cardiovasc Ultrasound 2003; 1: 4
   Google Scholar
• International Study Group for Behcet's Disease. Criteria for diagnosis of Behcet's disease., Lancet. 335. 1078–80
   Google Scholar
• Dimitrow P. P., Galderisi M., Rigo F. The non‐invasive documentation of coronary microcirculation impairment: role of transthoracic echocardiography. Cardiovasc Ultrasound 2005; 3: 18
   Google Scholar
• Saraste M., Koskenvuo J., Knuuti J., Toikka J., Laine H., Niemi P., et al. Coronary flow reserve: measurement with transthoracic Doppler echocardiography is reproducible and comparable with positron emission tomography. Clin Physiol 2001; 21: 114–22
   PubMedGoogle Scholar
• Lambertz H., Tries H. P., Stein T., Lethen H. Noninvasive assessment of coronary flow reserve with transthoracic signal‐enhanced Doppler echocardiography. J Am Soc Echocardiogr 1999; 12: 186–95
   PubMed Web of Science ®Google Scholar
• Korcarz C. E., Stein J. H. Noninvasive assessment of coronary flow reserve by echocardiography: technical considerations. J Am Soc Echocardiogr 2004; 17: 704–7
   Google Scholar
• Atzeni F., Sarzi‐Puttini P., Doria A., Boiardi L., Pipitone N., Salvarani C. Behcet's disease and cardiovascular involvement. Lupus 2005; 14: 723–6
   PubMed Web of Science ®Google Scholar
• al‐Dalaan A. N., al Balaa S. R., el Ramahi K., al‐Kawi Z., Bohlega S., Bahabri S., et al. Behcet's disease in Saudi Arabia. J Rheumatol 1994; 2: 658–61
   Google Scholar
• Haznedaroglu I. C., Ozcebe O. I., Ozdemir O., Celik I., Dundar S. V., Kirazli S. Impaired haemostatic kinetics and endothelial function in Behcet's disease. J Intern Med 1996; 240: 181–7
   Google Scholar
• Haznedaroglu I. C., Ozdemir O., Ozcebe O., Dundar S. V., Kirazli S. Circulating thrombomodulin as a clue of endothelial damage in Behcet's disease. Thromb Haemost 1996; 75: 974–5
   PubMed Web of Science ®Google Scholar
• Orem A., Yandi Y. E., Vanizor B., Cimsit G., Uydu H. A., Malkoc M. The evaluation of autoantibodies against oxidatively modified low‐density lipoprotein (LDL), susceptibility of LDL to oxidation, serum lipids and lipid hydroperoxide levels, total antioxidant status, antioxidant enzyme activities, and endothelial dysfunction in patients with Behcet's disease. Clin Biochem 2002; 35: 217–24
   PubMed Web of Science ®Google Scholar
• Buldanlioglu S., Turkmen S., Ayabakan H. B., Yenice N., Vardar M., Dogan S., et al. Nitric oxide, lipid peroxidation and antioxidant defence system in patients with active or inactive Behcet's disease. Br J Dermatol 2005; 153: 526–30
   PubMed Web of Science ®Google Scholar
• Chajek T., Fainaru M. Behçet's disease. Report of 41 cases and a review of the literature. Medicine 1975; 54: 179–96
   PubMed Web of Science ®Google Scholar
• Marks D. S., Gudapati S., Prisant L. M., Leir B., Donato‐Gonzalez C., Baller J. L., et al. Mortality in patients with microvascular disease. J Clin Hypertens 2004; 6: 304–09
   Google Scholar
• Rigo F., Cortigiani L., Gherardi S., Zanella C., Di Pede F., Pasanisi E., et al. The prognostic meaning of coronary flow reserve assessed by Doppler echocardiography in nonischemic dilated cardiomyopathy [abstract]. Circulation 2004; III–511, 110
   Google Scholar
• Rigo F., Pasanisi E., Gherardi S., Zanella C., Cutaia V., Cortigiani L., et al. Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy: a echocardiographic study [abstract]. Eur Heart J 2004; 25: 16
   Google Scholar
• Neglia D., Michelassi C., Trivieri M. G., Sambuceti G., Giorgetti A., Pratali L., et al. Prognostic role of myocardial blood flow impairment in idiopathic left ventricular dysfunction. Circulation 2002; 105: 186–93
   PubMedGoogle Scholar
• Britten M. B., Zeiher A. M., Schachinger V. Microvascular dysfunction in angiographically normal or mildly diseased coronary arteries predicts adverse cardiovascular long‐term outcome. Coron Artery Dis 2004; 15: 259–64
   Web of Science ®Google Scholar